<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="grin2a-dis" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">grin2a-dis</book-part-id>
      <title-group>
        <title><italic toggle="yes">GRIN2A</italic>-Related Speech Disorders and Epilepsy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Myers</surname>
            <given-names>Kenneth A</given-names>
          </name>
          <degrees>MD, PhD, FRCPC</degrees>
          <aff>University of Melbourne<break/>Melbourne, Australia</aff>
          <email>sfu.ken1@gmail.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Scheffer</surname>
            <given-names>Ingrid E</given-names>
          </name>
          <degrees>FAA, FAHMS, FRACP, MBBS, PhD</degrees>
          <aff>University of Melbourne<break/>Melbourne, Australia</aff>
          <email>i.scheffer@unimelb.edu.au</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>29</day>
          <month>9</month>
          <year>2016</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="ibm" document-type="chapter">
<italic toggle="yes">GNE</italic>-Related Myopathy</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="ftd-grn" document-type="chapter"><italic toggle="yes">GRN</italic>-Related Frontotemporal Dementia</related-object>
      <abstract id="grin2a-dis.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">GRIN2A</italic>-related speech disorders and epilepsy are characterized by speech disorders in all affected individuals and a range of epilepsy syndromes present in about 90%. Severe speech disorders observed can include dysarthria and speech dyspraxia, and both receptive and expressive language delay/regression; more mildly affected individuals may display subtly impaired intelligibility of conversational speech. Epilepsy features include seizure onset usually between ages three and six years, focal epilepsy with language and/or global developmental regression, and electroencephalogram (EEG) showing continuous spike-and-wave discharges in sleep or very active centrotemporal discharges. Seizure types include seizures associated with aura of perioral paresthesia, focal or focal motor seizures (often evolving to generalized tonic-clonic), and atypical absence seizures. Epilepsy syndromes can include: Landau-Kleffner syndrome (LKS), epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS), childhood epilepsy with centrotemporal spikes (CECTS), atypical childhood epilepsy with centrotemporal spikes (ACECTS), autosomal dominant rolandic epilepsy with speech dyspraxia (ADRESD), and infantile-onset epileptic encephalopathy.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of a <italic toggle="yes">GRIN2A</italic>-related speech disorder and epilepsy is established in a proband by the identification of a <italic toggle="yes">GRIN2A</italic> heterozygous pathogenic variant on molecular genetic testing.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Significant speech/language deficits require therapy from a speech pathologist. Seizures should be treated with antiepileptic drugs (AEDs). Many different AEDs may be effective, and no one medication has been demonstrated to be effective specifically for these disorders.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Monitoring for possible adverse effects of AEDs.</p>
          <p><italic toggle="yes">Surveillance:</italic> Developmental surveillance in all affected children; routine monitoring of speech and language by a speech pathologist should be considered for all children, particularly those diagnosed before reaching school age.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> In individuals with ECSWS, phenytoin, barbiturates and carbamazepine should be avoided as they are rarely effective, may worsen the EEG, and have negative effects on neuropsychological outcomes.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> It is appropriate to clarify the genetic status of apparently asymptomatic at-risk relatives in order to identify as early as possible those who would benefit from prompt evaluation for speech disorders and/or seizures and institution of treatment.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">GRIN2A</italic>-related speech disorders and epilepsy are inherited in an autosomal dominant manner. The proportion of <italic toggle="yes">GRIN2A</italic>-related speech disorders and epilepsy caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown. Each child of an individual with a <italic toggle="yes">GRIN2A</italic>-related speech disorder and epilepsy has a 50% chance of inheriting the <italic toggle="yes">GRIN2A</italic> pathogenic variant. Once the <italic toggle="yes">GRIN2A</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis are possible options.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="grin2a-dis.Diagnosis">
        <title>Diagnosis</title>
        <sec id="grin2a-dis.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>In general, a <italic toggle="yes">GRIN2A</italic> pathogenic variant <bold>should be considered</bold> in an individual presenting with an otherwise unexplained combination of the following speech disorders and/or epilepsy features, seizure types, epilepsy syndromes [<xref ref-type="bibr" rid="grin2a-dis.REF.tsai.2013.280">Tsai et al 2013</xref>].</p>
          <p>
            <bold>Speech disorders</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Acquired aphasia</p>
            </list-item>
            <list-item>
              <p>Auditory agnosia (impaired recognition of sounds)</p>
            </list-item>
            <list-item>
              <p>Dysarthria</p>
            </list-item>
            <list-item>
              <p>Speech dyspraxia</p>
            </list-item>
          </list>
          <p>
            <bold>Epilepsy features</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Onset in early childhood (usually age 3-6 years)</p>
            </list-item>
            <list-item>
              <p>Focal epilepsy with language and/or global developmental regression</p>
            </list-item>
            <list-item>
              <p>Electroencephalogram (EEG) showing continuous spike-and-wave discharges in sleep or very active centrotemporal discharges</p>
            </list-item>
          </list>
          <p>
            <bold>Seizure types</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Most commonly, focal seizures</p>
            </list-item>
            <list-item>
              <p>Sometimes occurring with an aura of perioral paresthesia, and often evolving to generalized tonic-clonic seizures</p>
            </list-item>
          </list>
          <p>
            <bold>Epilepsy syndromes</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Landau-Kleffner syndrome (LKS)</p>
            </list-item>
            <list-item>
              <p>Epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS)</p>
            </list-item>
            <list-item>
              <p>Childhood epilepsy with centrotemporal spikes (CECTS)</p>
            </list-item>
            <list-item>
              <p>Atypical childhood epilepsy with centrotemporal spikes (ACECTS)</p>
            </list-item>
            <list-item>
              <p>Autosomal dominant rolandic epilepsy with speech dyspraxia (ADRESD)</p>
            </list-item>
            <list-item>
              <p>Infantile-onset epileptic encephalopathy</p>
            </list-item>
          </list>
          <p>Note: Detailed descriptions of each epilepsy syndrome can be found in <xref ref-type="sec" rid="grin2a-dis.Clinical_Description">Clinical Description</xref>.</p>
        </sec>
        <sec id="grin2a-dis.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of <italic toggle="yes">GRIN2A</italic>-related speech disorder and epilepsy <bold>is established</bold> in a proband by identification of either a heterozygous pathogenic variant in <italic toggle="yes">GRIN2A</italic> or a heterozygous deletion involving <italic toggle="yes">GRIN2A</italic> using molecular genetic testing (see <xref ref-type="table" rid="grin2a-dis.T.summary_of_molecular_geneti">Table 1</xref>).</p>
          <p>Molecular genetic testing approaches can include a combination of <bold>gene-targeted testing</bold> (multi-gene panel or single-gene testing) or <bold>genomic testing</bold> (chromosomal microarray analysis or comprehensive genomic sequencing).</p>
          <p>Gene-targeted testing requires the clinician to develop a hypothesis about which gene(s) are likely involved, whereas genomic testing may not. The phenotypes of many genetic epileptic encephalopathies overlap; thus, most children with a <italic toggle="yes">GRIN2A</italic>-related speech disorder and epilepsy are diagnosed by CMA or multi-gene panel (see <xref ref-type="sec" rid="grin2a-dis.Recommended_Testing">Recommended Testing</xref>) or by comprehensive genomic sequencing (see <xref ref-type="sec" rid="grin2a-dis.Testing_to_Consider">Testing to Consider</xref>).</p>
          <sec id="grin2a-dis.Recommended_Testing">
            <title>Recommended Testing</title>
            <p><bold>Chromosomal microarray analysis (CMA</bold>) using oligonucleotide or SNP arrays is recommended first when developmental impairment/intellectual disability and/or dysmorphic features are present. The ability to determine the size of the deletion depends on the type of microarray used and the density of probes in the 16p13.2 region.</p>
            <p><bold>A multi-gene panel</bold> that incorporates both sequence analysis and deletion/duplication analysis and includes <italic toggle="yes">GRIN2A</italic> and other genes of interest (see <xref ref-type="sec" rid="grin2a-dis.Differential_Diagnosis">Differential Diagnosis</xref>) is recommended when epilepsy associated with speech dyspraxia and dysarthria are the primary findings (see <xref ref-type="table" rid="grin2a-dis.T.summary_of_molecular_geneti">Table 1</xref>). Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost while limiting secondary findings. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
          </sec>
          <sec id="grin2a-dis.Testing_to_Consider">
            <title>Testing to Consider</title>
            <p><bold>Comprehensive genomic sequencing</bold> (when available) including exome sequencing and genome sequencing may be considered if the phenotype alone is insufficient to support gene-targeted testing). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            <p><bold>Single-gene testing</bold> (sequence analysis of <italic toggle="yes">GRIN2A,</italic> followed by gene-targeted deletion/duplication analysis if no pathogenic variant is found may be considered first in individuals with features that are highly suggestive of <italic toggle="yes">GRIN2A</italic>-related speech disorder and epilepsy. However, because many of these features overlap with those of other genetic epileptic encephalopathies, multi-gene panels or comprehensive genomic testing are often performed in lieu of single-gene testing.</p>
            <table-wrap id="grin2a-dis.T.summary_of_molecular_geneti" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">GRIN2A</italic>-Related Speech Disorders and Epilepsy</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_grin2a-dis.T.summary_of_molecular_geneti_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_grin2a-dis.T.summary_of_molecular_geneti_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_grin2a-dis.T.summary_of_molecular_geneti_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method&#x000a0;<sup>3</sup></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_grin2a-dis.T.summary_of_molecular_geneti_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">GRIN2A</italic>
                    </td>
                    <td headers="hd_h_grin2a-dis.T.summary_of_molecular_geneti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_grin2a-dis.T.summary_of_molecular_geneti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">58/71</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_grin2a-dis.T.summary_of_molecular_geneti_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_grin2a-dis.T.summary_of_molecular_geneti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">13/71&#x000a0;<sup>6</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_grin2a-dis.T.summary_of_molecular_geneti_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">CMA</td>
                    <td headers="hd_h_grin2a-dis.T.summary_of_molecular_geneti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See footnote 7</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="grin2a-dis.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="grin2a-dis" object-id="grin2a-dis.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="grin2a-dis.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="grin2a-dis.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
                </fn>
                <fn id="grin2a-dis.TF.1.3">
                  <label>3. </label>
                  <p>Based on the combined results of published reports of <italic toggle="yes">GRIN2A</italic>-related disorders [<xref ref-type="bibr" rid="grin2a-dis.REF.endele.2010.1021">Endele et al 2010</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.reutlinger.2010.1870">Reutlinger et al 2010</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.lesca.2012.1526">Lesca et al 2012</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.carvill.2013.1073">Carvill et al 2013</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.devries.2013.482">DeVries &#x00026; Patel 2013</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.lemke.2013.1067">Lemke et al 2013</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.lesca.2013.1061">Lesca et al 2013</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.conroy.2014.858">Conroy et al 2014</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.dimassi.2014.370">Dimassi et al 2014</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.venkateswaran.2014.e75">Venkateswaran et al 2014</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.yuan.2014.3251">Yuan et al 2014</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.allen.2016.e12">Allen et al 2016</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.fainberg.2016.97">Fainberg et al 2016</xref>]. In one proband, <italic toggle="yes">GRIN2A</italic> was disrupted by an inherited translocation detectable by karyotype [<xref ref-type="bibr" rid="grin2a-dis.REF.endele.2010.1021">Endele et al 2010</xref>]; this was categorized as &#x0201c;detectable by sequence analysis.&#x0201d;</p>
                </fn>
                <fn id="grin2a-dis.TF.1.4">
                  <label>4. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="grin2a-dis.TF.1.5">
                  <label>5. </label>
                  <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and gene-targeted microarray designed to detect single-exon deletions or duplications. These methods will detect from single-exon to whole-gene deletions; however, breakpoints of large deletions and/or deletion of adjacent genes may not be detected by these methods.</p>
                </fn>
                <fn id="grin2a-dis.TF.1.6">
                  <label>6. </label>
                  <p>Of these 13 probands: 9 had small losses of genetic material (&#x0003c;292 kb), resulting in partial deletion of <italic toggle="yes">GRIN2A</italic>; 3 had large deletions (&#x0003e;0.9 Mb) affecting multiple genes (in 2 of the 3 <italic toggle="yes">GRIN2A</italic> was entirely deleted); and 1 had a small intragenic duplication.</p>
                </fn>
                <fn id="grin2a-dis.TF.1.7">
                  <label>7. </label>
                  <p>CMA is appropriate to define breakpoints of large deletions.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
      </sec>
      <sec id="grin2a-dis.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="grin2a-dis.Clinical_Description">
          <title>Clinical Description</title>
          <p>The clinical spectrum of <italic toggle="yes">GRIN2A</italic>-related speech disorders and epilepsy is broad and may vary within a family (e.g., from mild isolated speech impairment to rolandic epilepsy with speech dyspraxia) [<xref ref-type="bibr" rid="grin2a-dis.REF.turner.2015b.35">Turner et al 2015b</xref>].</p>
          <p>Disease progression is variable: some individuals have normal development and spontaneous remission of seizures, while others develop medically refractory epilepsy and severe developmental impairment. Language and/or global developmental regression often occurs in those with the more severe epilepsy-aphasia disorders.</p>
          <p><bold>Speech and language</bold> were impaired in 100% of individuals in a study of the speech manifestations of <italic toggle="yes">GRIN2A-</italic>related disorders [<xref ref-type="bibr" rid="grin2a-dis.REF.turner.2015a.586">Turner et al 2015a</xref>]. Abnormalities included dysarthria and speech dyspraxia, and both receptive and expressive language delay/regression.</p>
          <p>Mildly affected individuals may display subtly impaired intelligibility of conversational speech, most commonly characterized by hypernasality, imprecise consonant production, and impaired pitch and prosody [<xref ref-type="bibr" rid="grin2a-dis.REF.turner.2015a.586">Turner et al 2015a</xref>].</p>
          <p><bold>Intellectual disability,</bold> observed in 38%-67% of affected individuals, ranges from mild to severe [<xref ref-type="bibr" rid="grin2a-dis.REF.carvill.2013.1073">Carvill et al 2013</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.lemke.2013.1067">Lemke et al 2013</xref>].</p>
          <p><bold>Epilepsy</bold> occurs in approximately 90% of individuals [<xref ref-type="bibr" rid="grin2a-dis.REF.lemke.2013.1067">Lemke et al 2013</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.lesca.2013.1061">Lesca et al 2013</xref>].</p>
          <p>Seizure onset is typically between ages three and six years (mean 4.6 years), although individuals may present from infancy to adolescence [<xref ref-type="bibr" rid="grin2a-dis.REF.endele.2010.1021">Endele et al 2010</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.lesca.2012.1526">Lesca et al 2012</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.carvill.2013.1073">Carvill et al 2013</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.lemke.2013.1067">Lemke et al 2013</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.venkateswaran.2014.e75">Venkateswaran et al 2014</xref>].</p>
          <p>The most common seizure type overall is focal seizures. These are often associated with an aura of perioral paresthesia, and frequently evolve to generalized tonic-clonic convulsions. The predominant seizure type(s) in a given individual vary depending on which clinical syndrome is present.</p>
          <p>The most common <italic toggle="yes">GRIN2A</italic>-related speech disorder and epilepsy is epilepsy-aphasia syndromes (EAS), a spectrum of disorders that includes: Landau-Kleffner syndrome (LKS); epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS); childhood epilepsy with centrotemporal spikes (CECTS); atypical childhood epilepsy with centrotemporal spikes (ACECTS); and autosomal dominant rolandic epilepsy with speech dyspraxia (ADRESD) [<xref ref-type="bibr" rid="grin2a-dis.REF.tsai.2013.280">Tsai et al 2013</xref>]. Other epilepsy phenotypes can be broadly divided into infantile-onset epileptic encephalopathy and unclassified childhood epilepsy.</p>
          <p><bold>Landau-Kleffner syndrome (LKS)</bold> [<xref ref-type="bibr" rid="grin2a-dis.REF.landau.1957.523">Landau &#x00026; Kleffner 1957</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.wang.2006.105">Wang et al 2006</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.hughes.2011.247">Hughes 2011</xref>]</p>
          <list list-type="bullet">
            <list-item>
              <p>Onset in childhood (peak age range 5-8 years)</p>
            </list-item>
            <list-item>
              <p>Acquired aphasia, with auditory agnosia (impaired recognition of sounds) frequently described as the earliest feature</p>
            </list-item>
            <list-item>
              <p>Seizures in approximately 70% of cases, most commonly atypical absence, with focal motor, atonic, and focal seizures evolving to bilateral tonic-clonic seizures also described</p>
            </list-item>
            <list-item>
              <p>Developmental regression limited to language domains</p>
            </list-item>
            <list-item>
              <p>Normal development prior to onset of aphasia or isolated language impairment</p>
            </list-item>
            <list-item>
              <p>EEG showing frequent, sleep-activated, bilateral sharp and slow wave discharges (centrotemporal or perisylvian field), eventually evolving to continuous spike-and-wave in sleep (CSWS)</p>
            </list-item>
          </list>
          <p><bold>Epileptic encephalopathy with continuous spike-and-wave during sleep</bold>
<bold>(ECSWS)</bold> [<xref ref-type="bibr" rid="grin2a-dis.REF.van_bogaert.2013.635">Van Bogaert 2013</xref>]</p>
          <list list-type="bullet">
            <list-item>
              <p>Onset in childhood (peak age range 4-5 years)</p>
            </list-item>
            <list-item>
              <p>Seizures in approximately 80% of cases, most commonly hemiclonic or generalized tonic-clonic in sleep and atypical absence while awake</p>
            </list-item>
            <list-item>
              <p>Global developmental regression (as distinct from the pure language regression of LKS)</p>
            </list-item>
            <list-item>
              <p>EEG showing near-continuous (&#x0003e;85% of recording), bilateral sharp and slow wave discharges in slow wave sleep (i.e., CSWS)</p>
            </list-item>
          </list>
          <p><bold>Childhood epilepsy with centrotemporal spikes (CECTS)</bold> [<xref ref-type="bibr" rid="grin2a-dis.REF.guerrini.2012.9">Guerrini &#x00026; Pellacani 2012</xref>]</p>
          <list list-type="bullet">
            <list-item>
              <p>Onset is in childhood (peak age range 5-8 years; range 3-13 years).</p>
            </list-item>
            <list-item>
              <p>Seizures have a characteristic aura of perioral paresthesia which may involve the tongue, cheeks, and mouth. There is often speech arrest and a motor component involving the oropharyngeal muscles, unilateral facial tonic or clonic activity, and (less commonly) an upper limb. The majority of events occur during sleep, and classically involve drooling. Bilateral tonic-clonic seizures are also commonly observed.</p>
            </list-item>
            <list-item>
              <p>Seizure frequency is low: half of patients have fewer than six seizures in their lifetime.</p>
            </list-item>
            <list-item>
              <p>Epilepsy follows a self-limited course with duration less than five years in the majority of individuals.</p>
            </list-item>
            <list-item>
              <p>Development is essentially normal, though mild deficits in language, computation, and motor skills may be apparent when compared to healthy controls [<xref ref-type="bibr" rid="grin2a-dis.REF.staden.1998.242">Staden et al 1998</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.lillywhite.2009.2276">Lillywhite et al 2009</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.garciaramos.2015.1615">Garcia-Ramos et al 2015</xref>].</p>
            </list-item>
            <list-item>
              <p>EEG background is normal and shows focal epileptiform discharges from the centrotemporal regions, potentiated in sleep. In 40% of affected individuals, the centrotemporal discharges are bilateral and independent.</p>
            </list-item>
          </list>
          <p><bold>Atypical childhood epilepsy with centrotemporal spikes (ACECTS)</bold> [<xref ref-type="bibr" rid="grin2a-dis.REF.aicardi.1982.281">Aicardi &#x00026; Chevrie 1982</xref>]</p>
          <list list-type="bullet">
            <list-item>
              <p>Epilepsy course is similar to CECTS with onset and spontaneous remission occurring in childhood.</p>
            </list-item>
            <list-item>
              <p>Seizures are different from those seen in CECTS, and include negative myoclonus and atypical absence seizures.</p>
            </list-item>
            <list-item>
              <p>Developmental regression or slowing is coincident with seizure onset; however, long-term developmental outcome may be normal.</p>
            </list-item>
            <list-item>
              <p>EEG is similar to CECTS in that focal centrotemporal discharges potentiated in sleep are seen; however, focal or diffuse background slowing is also often present.</p>
            </list-item>
          </list>
          <p><bold>Autosomal dominant rolandic epilepsy with speech dyspraxia (ADRESD)</bold> [<xref ref-type="bibr" rid="grin2a-dis.REF.scheffer.2000.s19">Scheffer 2000</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.turner.2015b.35">Turner et al 2015b</xref>]</p>
          <list list-type="bullet">
            <list-item>
              <p>Seizure characteristics and epilepsy course are identical to CECTS in most family members. One individual had an encephalopathic presentation associated with cognitive regression.</p>
            </list-item>
            <list-item>
              <p>Affected individuals have oral and speech dyspraxia with dysarthria.</p>
            </list-item>
            <list-item>
              <p>Individuals may have isolated speech dysfunction without seizures.</p>
            </list-item>
            <list-item>
              <p>Cognitive function is usually within the normal range.</p>
            </list-item>
          </list>
          <p><bold>Infantile-onset epileptic encephalopathy</bold> [<xref ref-type="bibr" rid="grin2a-dis.REF.endele.2010.1021">Endele et al 2010</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.venkateswaran.2014.e75">Venkateswaran et al 2014</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.yuan.2014.3251">Yuan et al 2014</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.allen.2016.e12">Allen et al 2016</xref>]</p>
          <list list-type="bullet">
            <list-item>
              <p>Multiple different seizure types may be present, including tonic seizures, focal impaired awareness with evolution to bilateral seizures, infantile spasms, and myoclonic seizures.</p>
            </list-item>
            <list-item>
              <p>Severe intellectual disability was seen in the three individuals reported.</p>
            </list-item>
            <list-item>
              <p>EEG findings vary in the few reported cases and include background slowing, hypsarrhythmia, and focal spikes.</p>
            </list-item>
            <list-item>
              <p>Brain MRI may show bilateral parenchymal volume loss and thin corpus callosum.</p>
            </list-item>
          </list>
          <p><bold>Unclassified childhood-onset epilepsy</bold> [<xref ref-type="bibr" rid="grin2a-dis.REF.reutlinger.2010.1870">Reutlinger et al 2010</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.devries.2013.482">DeVries &#x00026; Patel 2013</xref>]</p>
          <list list-type="bullet">
            <list-item>
              <p>Focal seizures are the most commonly seen; myoclonic, eyelid myoclonia, and atypical absence have also been reported.</p>
            </list-item>
            <list-item>
              <p>Development ranges from normal to severely impaired.</p>
            </list-item>
            <list-item>
              <p>Mild dysmorphic features may be present in individuals with a contiguous gene deletion.</p>
            </list-item>
            <list-item>
              <p>EEG usually shows multifocal epileptiform discharges.</p>
            </list-item>
          </list>
          <p><bold>Contiguous gene deletions.</bold>
<xref ref-type="bibr" rid="grin2a-dis.REF.reutlinger.2010.1870">Reutlinger et al [2010]</xref> described three individuals with 16p13 deletions involving multiple genes and complete or partial heterozygous deletion of <italic toggle="yes">GRIN2A</italic>. All had mild dysmorphic features, intellectual disability, and epilepsy involving the rolandic region.</p>
          <p><bold>EEG</bold> most commonly shows bilateral epileptiform discharges (usually spike or spike-wave) in the central-temporal or temporal-parietal regions which may be independent or bilaterally synchronous. These abnormalities become more frequent in sleep, often evolving to continuous spike-and-wave in sleep (CSWS). CSWS is defined as near-continuous (&#x0003e;85% of non-REM sleep recording) bilateral sharp and slow wave discharges in slow wave sleep. CECTS is classically associated with a horizontal dipole; tangential dipole across the Sylvian fissure has been reported in LKS [<xref ref-type="bibr" rid="grin2a-dis.REF.morrell.1995.1529">Morrell et al 1995</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.dalla_bernardina.2005">Dalla Bernardina et al 2005</xref>].</p>
          <p><bold>Brain imaging.</bold> Brain MRI is normal in the vast majority. Severely affected individuals may have enlargement of extra-axial spaces and a thin corpus callosum [<xref ref-type="bibr" rid="grin2a-dis.REF.reutlinger.2010.1870">Reutlinger et al 2010</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.pierson.2014.190">Pierson et al 2014</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.venkateswaran.2014.e75">Venkateswaran et al 2014</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.yuan.2014.3251">Yuan et al 2014</xref>]. One individual with focal cortical dysplasia was reported [<xref ref-type="bibr" rid="grin2a-dis.REF.lesca.2013.1061">Lesca et al 2013</xref>].</p>
          <p>Positron emission tomography (PET) showing diffuse cortical hypometabolism was reported in one individual [<xref ref-type="bibr" rid="grin2a-dis.REF.devries.2013.482">DeVries &#x00026; Patel 2013</xref>].</p>
        </sec>
        <sec id="grin2a-dis.GenotypePhenotype_Correlation">
          <title>Genotype-Phenotype Correlations</title>
          <p>Genotype-phenotype correlation is observed in a number of families in which all individuals heterozygous for the <italic toggle="yes">GRIN2A</italic> pathogenic variant have an epilepsy-aphasia syndrome (EAS) phenotype. However, the specific EAS phenotype may vary considerably within the family, including one individual with isolated speech dysfunction and another with epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS) [<xref ref-type="bibr" rid="grin2a-dis.REF.carvill.2013.1073">Carvill et al 2013</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.lemke.2013.1067">Lemke et al 2013</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.lesca.2013.1061">Lesca et al 2013</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.turner.2015a.586">Turner et al 2015a</xref>].</p>
          <p>For single-nucleotide variants (SNVs) and small intragenic copy number variants (CNVs), the genomic region in which the pathogenic variant occurs does not appear to have any relationship to the phenotype. Specifically, the pathogenic variants associated with infantile-onset epileptic encephalopathies do not cluster in a region distinct from the location of pathogenic variants associated with the epilepsy-aphasia syndromes (EAS).</p>
        </sec>
        <sec id="grin2a-dis.Penetrance">
          <title>Penetrance</title>
          <p><italic toggle="yes">GRIN2A</italic>-related speech disorders and epilepsy show incomplete but high penetrance and variable expressivity.</p>
          <p>Penetrance is not clearly different for males and females.</p>
        </sec>
        <sec id="grin2a-dis.Nomenclature">
          <title>Nomenclature</title>
          <p>Landau-Kleffner syndrome (LKS) has also been referred to as epileptic acquired aphasia.</p>
          <p>Epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS) has also been referred to as continuous spike-and-wave during slow-wave sleep (CSWS) and electrical status epilepticus during sleep (ESES).</p>
          <p>Childhood epilepsy with centrotemporal spikes (CECTS) has been commonly referred to as benign epilepsy with centrotemporal spikes (BECTS) and benign rolandic epilepsy of childhood (BREC).</p>
          <p>Atypical childhood epilepsy with centrotemporal spikes (ACECTS) has been known as atypical benign partial epilepsy (ABPE), pseudo-Lennox syndrome, and atonic-benign childhood epilepsy with centrotemporal spikes.</p>
        </sec>
        <sec id="grin2a-dis.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of <italic toggle="yes">GRIN2A</italic>-related speech disorders and epilepsy in the general population is unknown; however, estimates can be made for some of the classic disorders.</p>
          <p><italic toggle="yes">GRIN2A</italic> pathogenic variants account for 9%-20% of epilepsy-aphasia syndrome (EAS), with pathogenic variants more likely to be present in persons with more severe phenotypes and a positive family history [<xref ref-type="bibr" rid="grin2a-dis.REF.lesca.2012.1526">Lesca et al 2012</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.carvill.2013.1073">Carvill et al 2013</xref>].</p>
          <p><italic toggle="yes">GRIN2A</italic> pathogenic variants are present in:</p>
          <list list-type="bullet">
            <list-item>
              <p>4.8%-7.7% of Landau-Kleffner syndrome (LKS)</p>
            </list-item>
            <list-item>
              <p>17.6% of epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS)</p>
            </list-item>
            <list-item>
              <p>0%-4.9% of childhood epilepsy with centrotemporal spikes (CECTS)</p>
            </list-item>
            <list-item>
              <p>13.5% of atypical childhood epilepsy with centrotemporal spikes (ACECTS)</p>
            </list-item>
            <list-item>
              <p>2% of early-onset epileptic encephalopathy</p>
            </list-item>
          </list>
          <p>[<xref ref-type="bibr" rid="grin2a-dis.REF.lemke.2013.1067">Lemke et al 2013</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.conroy.2014.858">Conroy et al 2014</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.allen.2016.e12">Allen et al 2016</xref>].</p>
        </sec>
      </sec>
      <sec id="grin2a-dis.Genetically_Related_Allelic_D">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be definitely associated with pathogenic variants in <italic toggle="yes">GRIN2A</italic>.</p>
      </sec>
      <sec id="grin2a-dis.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>
          <bold>Non-<italic toggle="yes">GRIN2</italic>-related genetic epilepsy</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p>Epilepsy-aphasia syndrome (EAS). While <italic toggle="yes">GRIN2A</italic> is the gene most commonly associated with EAS, the majority of individuals with this group of syndromes do not have an identified genetic cause. A number of CNVs have been associated with EAS in individual cases. Pathogenic variants in <italic toggle="yes">RBFOX1</italic> and <italic toggle="yes">RBFOX3</italic> may play a contributory role in some cases [<xref ref-type="bibr" rid="grin2a-dis.REF.lal.2013.e73323">Lal et al 2013</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.turner.2015b.35">Turner et al 2015b</xref>]. At present, no clinical features differentiate <italic toggle="yes">GRIN2A</italic>-related EAS from EAS of other genetic causes.</p>
          </list-item>
          <list-item>
            <p>Non-EAS childhood-onset focal epilepsy and infantile-onset epileptic encephalopathy. Each phenotype has only a small number of reported cases associated with a <italic toggle="yes">GRIN2A</italic> pathogenic variant. Clinical data currently available are insufficient to distinguish those with a <italic toggle="yes">GRIN2A</italic> pathogenic variant from those with other genetic causes.</p>
          </list-item>
        </list>
        <p><bold>Non-genetic causes of epilepsy.</bold> Focal epilepsy and epileptic encephalopathy may have many non-genetic causes, including autoimmune and infectious processes. A non-genetic cause should be more strongly considered when a history of any of the following is present:</p>
        <list list-type="bullet">
          <list-item>
            <p>Maternal substance abuse during pregnancy</p>
          </list-item>
          <list-item>
            <p>Significant complications in the perinatal period</p>
          </list-item>
          <list-item>
            <p>Significant cerebral insult (e.g., central nervous system infection, hypoxic-ischemic injury, major head trauma, toxic ingestion/exposure)</p>
          </list-item>
        </list>
        <p><bold>Non-<italic toggle="yes">GRIN2A</italic>-related genetic language impairment.</bold> A severe speech and language disorder that primarily involves developmental verbal dyspraxia is caused by pthogenic variants in <italic toggle="yes">FOXP2</italic> (see <related-object link-type="booklink" source-id="gene" document-id="foxp2-sl-dis" document-type="chapter"><italic toggle="yes">FOXP2</italic>-Related Speech and Language Disorders</related-object>) [<xref ref-type="bibr" rid="grin2a-dis.REF.lai.2001.519">Lai et al 2001</xref>]. <italic toggle="yes">FOXP2</italic> regulates <italic toggle="yes">CNTNAP2</italic>, and <italic toggle="yes">CNTNAP2</italic> missense variants and deletions have been associated with childhood apraxia of speech; however, evidence of a causative link is at present limited [<xref ref-type="bibr" rid="grin2a-dis.REF.worthey.2013.29">Worthey et al 2013</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.centanni.2015.536">Centanni et al 2015</xref>].</p>
        <p><bold>Hearing impairment</bold> is a common cause of language-specific developmental delay or regression, thus in children with delayed speech development or regression in speech, the auditory system should be assessed (see <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Hereditary Hearing Loss and Deafness Overview</related-object>).</p>
        <p><bold>Structural brain abnormality.</bold> Brain malformations and acquired structural brain anomalies can present with a constellation of symptoms that can mimic the <italic toggle="yes">GRIN2A</italic>-related disorders. Worster-Drought syndrome (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/185480">OMIM</ext-link>) involves congenital bilateral perisylvian lesions, most commonly polymicrogyria [<xref ref-type="bibr" rid="grin2a-dis.REF.christen.2000.122">Christen et al 2000</xref>]. Affected children typically have seizures, expressive language delay, dysarthria, and oromotor apraxia.</p>
      </sec>
      <sec id="grin2a-dis.Management">
        <title>Management</title>
        <sec id="grin2a-dis.Evaluations_Following_Initial">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with a <italic toggle="yes">GRIN2A</italic>-related speech disorder and epilepsy, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Consultation with a speech and language pathologist</p>
            </list-item>
            <list-item>
              <p>Epilepsy consultation (if not done at the time of initial assessment)</p>
            </list-item>
            <list-item>
              <p>Sleep-deprived or sleep EEG with monitoring to capture slow-wave sleep (if not done at the time of initial assessment), as this is essential to diagnosing or excluding continuous spike-and-wave in sleep (CSWS).</p>
            </list-item>
            <list-item>
              <p>Neuropsychological assessment</p>
            </list-item>
            <list-item>
              <p>Hearing testing</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="grin2a-dis.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Speech/language deficits.</bold> Individuals with significant speech/language deficits may benefit from therapy by a speech pathologist. The therapies, which are individualized to the specific speech disorder, often include linguistic approaches and augmentative and alternative communication [<xref ref-type="bibr" rid="grin2a-dis.REF.murray.2014.486">Murray et al 2014</xref>].</p>
          <p><bold>Seizures,</bold> if present, should be treated with antiepileptic drugs (AEDs). Many different AEDs may be effective, and no one medication has been demonstrated to be effective specifically for <italic toggle="yes">GRIN2A</italic>-related disorders.</p>
          <p>In one individual a good response to refractory epilepsy was achieved with topiramate [<xref ref-type="bibr" rid="grin2a-dis.REF.venkateswaran.2014.e75">Venkateswaran et al 2014</xref>].</p>
          <p>In one individual seizure burden was reduced with the addition of memantine; however, cognitive function did not improve [<xref ref-type="bibr" rid="grin2a-dis.REF.pierson.2014.190">Pierson et al 2014</xref>].</p>
          <p>Ketogenic diet and vagal nerve stimulator may also be considered in patients with refractory epilepsy.</p>
          <p>Treatment for epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS) and Landau-Kleffner syndrome (LKS) includes AEDs such as valproic acid, benzodiazepines, and corticosteroids. Sulthiame, ethosuximide, and levetiracetam may also be effective.</p>
          <p>Of note, intravenous immunoglobulin has not been proven to be efficacious [<xref ref-type="bibr" rid="grin2a-dis.REF.striano.2013.360">Striano &#x00026; Capovilla 2013</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.van_bogaert.2013.635">Van Bogaert 2013</xref>].</p>
          <p><bold>Caregivers.</bold> For information on non-medical interventions and coping strategies for parents or caregivers of children diagnosed with epilepsy, see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.epilepsy.com/sites/core/files/atoms/files/English_Toolkit_updated%202014.pdf">Epilepsy &#x00026; My Child Toolkit</ext-link>.</p>
        </sec>
        <sec id="grin2a-dis.Prevention_of_Secondary_Compl">
          <title>Prevention of Secondary Complications</title>
          <p><bold>AEDs</bold> are associated with possible adverse reactions (e.g., sedation, gastrointestinal symptoms, changes in appetite [increase or decrease], weight gain or loss, and rash) which vary according to the specific medication. Patients on AEDs should be monitored closely for adverse reactions and, if they develop, a change to an alternate AED should be considered.</p>
          <p><bold>Corticosteroids</bold> are associated with a wide variety of possible adverse reactions, including weight gain with cushingoid appearance, skin thinning and purpura, alopecia, acne, posterior subscapular cataract, glaucoma, exophthalmos, cardiac arrhythmias, hypertension, gastrointestinal upset, pancreatitis, hypokalemia, osteoporosis, avascular necrosis, myopathy, behavioral/psychiatric disturbance, diabetes mellitus, adrenal insufficiency, and increased infection risk. If complications of corticosteroid therapy become of concern, gradual tapering and alternate therapy should be considered.</p>
        </sec>
        <sec id="grin2a-dis.Surveillance">
          <title>Surveillance</title>
          <p>Routine monitoring of speech and language by a speech pathologist should be considered for all children, particularly those diagnosed before reaching school age.</p>
          <p>Developmental surveillance should be conducted in all affected children.</p>
        </sec>
        <sec id="grin2a-dis.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>In individuals with epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS), phenytoin, barbiturates and carbamazepine should be avoided as they are rarely effective, may worsen the EEG, and have negative effects on neuropsychological outcomes [<xref ref-type="bibr" rid="grin2a-dis.REF.striano.2013.360">Striano &#x00026; Capovilla 2013</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.van_bogaert.2013.635">Van Bogaert 2013</xref>].</p>
        </sec>
        <sec id="grin2a-dis.Evaluation_of_Relatives_at_Ri">
          <title>Evaluation of Relatives at Risk</title>
          <p>Using molecular genetic testing for the <italic toggle="yes">GRIN2A</italic> pathogenic variant found in an affected family member, it is appropriate to evaluate apparently asymptomatic at-risk relatives in order to identify as early as possible those who would benefit from institution of treatment. Of note, some individuals heterozygous for a <italic toggle="yes">GRIN2A</italic> pathogenic variant who have only relatively mild speech dysfunction may benefit from early evaluation and intervention by a speech and language pathologist.</p>
          <p>See <xref ref-type="sec" rid="grin2a-dis.Related_Genetic_Counseling_Is">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="grin2a-dis.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="grin2a-dis.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="grin2a-dis.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">GRIN2A</italic>-related speech disorders and epilepsy are inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="grin2a-dis.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Some individuals diagnosed with a <italic toggle="yes">GRIN2A</italic>-related speech disorder and epilepsy have an affected parent. There is considerable clinical variability within families.</p>
            </list-item>
            <list-item>
              <p>A proband with a <italic toggle="yes">GRIN2A</italic>-related speech disorder and epilepsy may have a <italic toggle="yes">de novo GRIN2A</italic> pathogenic variant; however, the proportion of <italic toggle="yes">GRIN2A</italic>-related speech disorders and epilepsy caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown because to date an insufficient number of parents of simplex cases (i.e., a single occurrence in a family) have been tested.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, possible explanations include a <italic toggle="yes">de novo</italic> pathogenic variant in the proband or germline mosaicism in a parent. (Although no instances of germline mosaicism have been reported, it remains a possibility.)</p>
            </list-item>
            <list-item>
              <p>The family history of some individuals diagnosed with a <italic toggle="yes">GRIN2A</italic>-related speech disorder and epilepsy may appear to be negative because of failure to recognize the disorder in family members, reduced penetrance, or variable clinical severity. Therefore, an apparently negative family history cannot be confirmed unless molecular genetic testing has been performed on the parents of the proband.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents. If the parents have been tested for the <italic toggle="yes">GRIN2A</italic> pathogenic variant identified in the proband and:</p>
              <list list-type="bullet">
                <list-item>
                  <p>A parent of the proband has the <italic toggle="yes">GRIN2A</italic> pathogenic variant, the risk to the sibs of inheriting the variant is 50%. Some familial cases have demonstrated reduced penetrance and phenotypic variability.</p>
                </list-item>
                <list-item>
                  <p>The <italic toggle="yes">GRIN2A</italic> pathogenic variant cannot be detected in the leukocyte DNA of either parent, the risk to sibs is presumed to be low but greater than that of the general population because of the theoretic possibility of germline mosaicism.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>If the parents have not been tested for the <italic toggle="yes">GRIN2A</italic> pathogenic variant but are clinically unaffected, the risk to the sibs of a proband appears to be low. However, sibs of a proband with clinically unaffected parents are still presumed to be at increased risk for a <italic toggle="yes">GRIN2A</italic>-related speech disorder and epilepsy because of the possibility of reduced penetrance in a parent or the theoretic possibility of parental germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with a <italic toggle="yes">GRIN2A</italic>-related speech disorder and epilepsy has a 50% chance of inheriting the <italic toggle="yes">GRIN2A</italic> pathogenic variant. Some familial cases have demonstrated reduced penetrance and phenotypic variability.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents: if a parent has the <italic toggle="yes">GRIN2A</italic> pathogenic variant, his or her family members may be at risk.</p>
        </sec>
        <sec id="grin2a-dis.Related_Genetic_Counseling_Is">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="grin2a-dis.Evaluation_of_Relatives_at_Ri">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <italic toggle="yes">de novo</italic>. However, non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="grin2a-dis.Prenatal_Testing_and_Preimpla">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">GRIN2A</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for a <italic toggle="yes">GRIN2A</italic>-related speech disorder and epilepsy are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="grin2a-dis.Resources">
        <title>Resources</title>
      </sec>
      <sec id="grin2a-dis.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="grin2a-dis.Molecular_Genetic_Pathogenesi">
          <title>Molecular Genetic Pathogenesis</title>
          <p>N-methyl-D-aspartate (NMDA) receptors are glutamate-activated ion channels permeable to sodium, calcium, and potassium ions, thought to be primarily important in mediation of excitatory processes in the human brain. The NMDA receptor is a heterotetramer composed of two NMDA-receptor 1 subunits (NR1) and two different NMDA-receptor subunits (NR2A and NR2B). The NR2A subunit is encoded by <italic toggle="yes">GRIN2A</italic> [<xref ref-type="bibr" rid="grin2a-dis.REF.matta.2011.339">Matta et al 2011</xref>].</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">GRIN2A</italic> comprises 14 exons [<xref ref-type="bibr" rid="grin2a-dis.REF.endele.2010.1021">Endele et al 2010</xref>]. See <related-object source-id="gene" document-id="grin2a-dis" object-id="grin2a-dis.molgen.TA">Table A</related-object>, <bold>Gene</bold> for a detailed summary of gene and protein information.</p>
          <p><bold>Pathogenic variants.</bold> Of probands with pathogenic variants, 41/71 (58%) had missense variants, 8/71 (11%) nonsense variants, 8/71 (11%) splice site variants, and 13/71 (18%) copy number variations; the remaining proband had a translocation affecting <italic toggle="yes">GRIN2A</italic> without loss of genetic material.</p>
          <p>One recurrent splice site variant (c.1007+1G&#x0003e;A) located in intron 4 has been identified in six apparently unrelated probands [<xref ref-type="bibr" rid="grin2a-dis.REF.carvill.2013.1073">Carvill et al 2013</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.lemke.2013.1067">Lemke et al 2013</xref>]. Four missense variants (c.1553G&#x0003e;A, c.1845C&#x0003e;A, c.2146G&#x0003e;A, and c.2927A&#x0003e;G) have been reported in two probands each [<xref ref-type="bibr" rid="grin2a-dis.REF.endele.2010.1021">Endele et al 2010</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.lesca.2013.1061">Lesca et al 2013</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.conroy.2014.858">Conroy et al 2014</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.allen.2016.e12">Allen et al 2016</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.fainberg.2016.97">Fainberg et al 2016</xref>].</p>
          <p>In two non-familial cases, a recurrent pathogenic variant (c.1845C&#x0003e;A) has been associated with severe intellectual disability and refractory early-onset epileptic encephalopathy [<xref ref-type="bibr" rid="grin2a-dis.REF.endele.2010.1021">Endele et al 2010</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.allen.2016.e12">Allen et al 2016</xref>].</p>
          <table-wrap id="grin2a-dis.T.grin2a_pathogenic_variants" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p><italic toggle="yes">GRIN2A</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                  <th id="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1007+1G&#x0003e;A</td>
                  <td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Splice region</td>
                  <td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_3" rowspan="5" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000833.4">NM_000833.4</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000824.1">NP_000824.1</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1553G&#x0003e;A</td>
                  <td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg518His</td>
                </tr>
                <tr>
                  <td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1845C&#x0003e;A</td>
                  <td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn615Lys</td>
                </tr>
                <tr>
                  <td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2146G&#x0003e;A</td>
                  <td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala716Thr</td>
                </tr>
                <tr>
                  <td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2927A&#x0003e;G</td>
                  <td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn976Ser</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> The human <italic toggle="yes">GRIN2A</italic> gene product contains 1464 amino acids.</p>
          <p><bold>Abnormal gene product.</bold> In in vitro models, NMDA receptors with <italic toggle="yes">GRIN2A</italic> pathogenic variants demonstrate reduced inhibition by both Zn<sup>2+</sup> and Mg<sup>2+</sup>, and have shorter closed-state and longer open-state durations, all of which suggests that <italic toggle="yes">GRIN2A</italic> pathogenic variants lead to increased neuronal excitability [<xref ref-type="bibr" rid="grin2a-dis.REF.endele.2010.1021">Endele et al 2010</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.lesca.2012.1526">Lesca et al 2012</xref>, <xref ref-type="bibr" rid="grin2a-dis.REF.lemke.2013.1067">Lemke et al 2013</xref>].</p>
        </sec>
      </sec>
      <sec id="grin2a-dis.References">
        <title>References</title>
        <sec id="grin2a-dis.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="grin2a-dis.Literature_Cited.reflist0">
            <ref id="grin2a-dis.REF.aicardi.1982.281">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aicardi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chevrie</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <article-title>Atypical benign partial epilepsy of childhood.</article-title>
                <source>Dev Med Child Neurol.</source>
                <year>1982</year>
                <volume>24</volume>
                <fpage>281</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">6807733</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.allen.2016.e12">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conroy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shahwan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Correa</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pena</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCreary</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magalhaes</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ennis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <article-title>Unexplained early onset epileptic encephalopathy: Exome screening and phenotype expansion.</article-title>
                <source>Epilepsia.</source>
                <year>2016</year>
                <volume>57</volume>
                <fpage>e12</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">26648591</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.carvill.2013.1073">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carvill</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Regan</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yendle</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Roak</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lozovaya</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruneau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burnashev</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cook</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geraghty</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadleir</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsai</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webster</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ouvrier</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damiano</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shendure</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hildebrand</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szepetowski</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mefford</surname>
                    <given-names>HC</given-names>
                  </name>
                </person-group>
                <article-title>GRIN2A mutations cause epilepsy-aphasia spectrum disorders.</article-title>
                <source>Nat Genet.</source>
                <year>2013</year>
                <volume>45</volume>
                <fpage>1073</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23933818</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.centanni.2015.536">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Centanni</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanmann</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iuzzini-Seigel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartlett</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanger</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogan</surname>
                    <given-names>TP</given-names>
                  </name>
                </person-group>
                <article-title>The role of candidate-gene <italic toggle="yes">CNTNAP2</italic> in childhood apraxia of speech and specific language impairment.</article-title>
                <source>Am J Med Genet B Neuropsychiatr Genet.</source>
                <year>2015</year>
                <volume>168</volume>
                <fpage>536</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">26097074</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.christen.2000.122">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Christen</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanefeld</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kruse</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imhauser</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ernst</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finkenstaedt</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Foix-Chavany-Marie (anterior operculum) syndrome in childhood: a reappraisal of Worster-Drought syndrome.</article-title>
                <source>Dev Med Child Neurol.</source>
                <year>2000</year>
                <volume>42</volume>
                <fpage>122</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">10698330</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.conroy.2014.858">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Conroy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGettigan</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCreary</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shah</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parry-Fielder</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moran</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanrahan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deonna</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korff</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webb</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ennis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <article-title>Towards the identification of a genetic basis for Landau-Kleffner syndrome.</article-title>
                <source>Epilepsia.</source>
                <year>2014</year>
                <volume>55</volume>
                <fpage>858</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">24828792</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.dalla_bernardina.2005">
              <mixed-citation publication-type="book">Dalla Bernardina B, Sgr&#x000f2; V, Fejerman N. Epilepsy with centro-temporal spikes and related syndromes. In: Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolf P, eds. <italic toggle="yes">Epileptic Syndromes in Infancy, Childhood and Adolescence.</italic> 4 ed. Montrouge, France, John Libbey Eurotext. 2005:203-26.</mixed-citation>
            </ref>
            <ref id="grin2a-dis.REF.devries.2013.482">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>DeVries</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <article-title>Two patients with a GRIN2A mutation and childhood-onset epilepsy.</article-title>
                <source>Pediatr Neurol.</source>
                <year>2013</year>
                <volume>49</volume>
                <fpage>482</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">24125812</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.dimassi.2014.370">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dimassi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labalme</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lesca</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudolf</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruneau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirsch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arzimanoglou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Motte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Saint Martin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boutry-Kryza</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cloarec</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benitto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ameil</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edery</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryvlin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Bellescize</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szepetowski</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanlaville</surname>
                    <given-names>D.</given-names>
                  </name>
                </person-group>
                <article-title>A subset of genomic alterations detected in rolandic epilepsies contains candidate or known epilepsy genes including GRIN2A and PRRT2.</article-title>
                <source>Epilepsia.</source>
                <year>2014</year>
                <volume>55</volume>
                <fpage>370</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">24372385</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.endele.2010.1021">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Endele</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geider</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Popp</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanova</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kortum</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fritsch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pientka</surname>
                    <given-names>FK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hellenbroich</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalscheuer</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlhase</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moog</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rappold</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rauch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ropers</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Spiczak</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonnies</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villeneuve</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villard</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zenker</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laube</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wieczorek</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Maldergem</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kutsche</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes.</article-title>
                <source>Nat Genet.</source>
                <year>2010</year>
                <volume>42</volume>
                <fpage>1021</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20890276</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.fainberg.2016.97">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fainberg</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harper</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tchapyjnikov</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mikati</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <article-title>Response to immunotherapy in a patient with Landau-Kleffner syndrome and GRIN2A mutation.</article-title>
                <source>Epileptic Disord.</source>
                <year>2016</year>
                <volume>18</volume>
                <fpage>97</fpage>
                <lpage>100</lpage>
                <pub-id pub-id-type="pmid">26806548</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.garciaramos.2015.1615">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garcia-Ramos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dabbs</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsu</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stafstrom</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zawadzki</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seidenberg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prabhakaran</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hermann</surname>
                    <given-names>BP</given-names>
                  </name>
                </person-group>
                <article-title>Cognition and brain development in children with benign epilepsy with centrotemporal spikes.</article-title>
                <source>Epilepsia.</source>
                <year>2015</year>
                <volume>56</volume>
                <fpage>1615</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">26337046</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.guerrini.2012.9">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellacani</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Benign childhood focal epilepsies.</article-title>
                <source>Epilepsia.</source>
                <year>2012</year>
                <volume>53</volume>
                <supplement>Suppl 4</supplement>
                <fpage>9</fpage>
                <lpage>18</lpage>
                <pub-id pub-id-type="pmid">22946717</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.hughes.2011.247">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <article-title>A review of the relationships between Landau-Kleffner syndrome, electrical status epilepticus during sleep, and continuous spike-waves during sleep.</article-title>
                <source>Epilepsy Behav.</source>
                <year>2011</year>
                <volume>20</volume>
                <fpage>247</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">21242107</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.lai.2001.519">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hurst</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vargha-Khadem</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monaco</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <article-title>A forkhead-domain gene is mutated in a severe speech and language disorder.</article-title>
                <source>Nature.</source>
                <year>2001</year>
                <volume>413</volume>
                <fpage>519</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">11586359</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.lal.2013.e73323">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lal</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reinthaler</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altmuller</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toliat</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiele</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nurnberg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerche</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moller</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muhle</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sander</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimprich</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neubauer</surname>
                    <given-names>BA</given-names>
                  </name>
                </person-group>
                <article-title>RBFOX1 and RBFOX3 mutations in rolandic epilepsy.</article-title>
                <source>PLoS One.</source>
                <year>2013</year>
                <volume>8</volume>
                <fpage>e73323</fpage>
                <pub-id pub-id-type="pmid">24039908</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.landau.1957.523">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Landau</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleffner</surname>
                    <given-names>FR</given-names>
                  </name>
                </person-group>
                <article-title>Syndrome of acquired aphasia with convulsive disorder in children.</article-title>
                <source>Neurology.</source>
                <year>1957</year>
                <volume>7</volume>
                <fpage>523</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">13451887</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.lemke.2013.1067">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lemke</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lal</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reinthaler</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steiner</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nothnagel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alber</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geider</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laube</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwake</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finsterwalder</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franke</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schilhabel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jahn</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muhle</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boor</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Paesschen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caraballo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fejerman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weckhuysen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larsen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moller</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hjalgrim</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Addis</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pal</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veri</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaher</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talvik</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dimova</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrero Lopez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serratosa</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linnankivi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehesjoki</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruf</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolff</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buerki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wohlrab</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kroell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Datta</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fiedler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurlemann</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kluger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haberlandt</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kutzer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>YG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feucht</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinbock</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neophythou</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronen</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gruber-Sedlmayr</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geldner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herms</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altmuller</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toliat</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiele</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nurnberg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilhelm</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephani</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helbig</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerche</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimprich</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neubauer</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biskup</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Spiczak</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes.</article-title>
                <source>Nat Genet.</source>
                <year>2013</year>
                <volume>45</volume>
                <fpage>1067</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">23933819</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.lesca.2013.1061">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lesca</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudolf</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruneau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lozovaya</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labalme</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boutry-Kryza</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salmi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsintsadze</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Addis</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Motte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wright</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsintsadze</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doummar</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lascelles</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strug</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waters</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Bellescize</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vrielynck</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Saint Martin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ville</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryvlin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arzimanoglou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirsch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pal</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burnashev</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanlaville</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szepetowski</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction.</article-title>
                <source>Nat Genet.</source>
                <year>2013</year>
                <volume>45</volume>
                <fpage>1061</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23933820</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.lesca.2012.1526">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lesca</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudolf</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labalme</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirsch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arzimanoglou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Motte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Saint Martin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valenti</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boulay</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Bellescize</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keo-Kosal</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boutry-Kryza</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edery</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanlaville</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szepetowski</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Epileptic encephalopathies of the Landau-Kleffner and continuous spike and waves during slow-wave sleep types: genomic dissection makes the link with autism.</article-title>
                <source>Epilepsia.</source>
                <year>2012</year>
                <volume>53</volume>
                <fpage>1526</fpage>
                <lpage>38</lpage>
                <pub-id pub-id-type="pmid">22738016</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.lillywhite.2009.2276">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lillywhite</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saling</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbott</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Archer</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vears</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>GD</given-names>
                  </name>
                </person-group>
                <article-title>Neuropsychological and functional MRI studies provide converging evidence of anterior language dysfunction in BECTS.</article-title>
                <source>Epilepsia.</source>
                <year>2009</year>
                <volume>50</volume>
                <fpage>2276</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">19292755</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.matta.2011.339">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matta</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashby</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanz-Clemente</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roche</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isaac</surname>
                    <given-names>JT</given-names>
                  </name>
                </person-group>
                <article-title>mGluR5 and NMDA receptors drive the experience- and activity-dependent NMDA receptor NR2B to NR2A subunit switch.</article-title>
                <source>Neuron.</source>
                <year>2011</year>
                <volume>70</volume>
                <fpage>339</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">21521618</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.morrell.1995.1529">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morrell</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whisler</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoeppner</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Toledo-Morrell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierre-Louis</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanner</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buelow</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ristanovic</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Landau-Kleffner syndrome. Treatment with subpial intracortical transection.</article-title>
                <source>Brain.</source>
                <year>1995</year>
                <volume>118</volume>
                <fpage>1529</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">8595482</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.murray.2014.486">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCabe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballard</surname>
                    <given-names>KJ</given-names>
                  </name>
                </person-group>
                <article-title>A systematic review of treatment outcomes for children with childhood apraxia of speech.</article-title>
                <source>Am J Speech Lang Pathol.</source>
                <year>2014</year>
                <volume>23</volume>
                <fpage>486</fpage>
                <lpage>504</lpage>
                <pub-id pub-id-type="pmid">24686844</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.pierson.2014.190">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pierson</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marsh</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuentes-Fajardo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adams</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markello</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Golas</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simeonov</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holloman</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tankovic</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karamchandani</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schreiber</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullikin</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tifft</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toro</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boerkoel</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traynelis</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <article-title>GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine.</article-title>
                <source>Ann Clin Transl Neurol.</source>
                <year>2014</year>
                <volume>1</volume>
                <fpage>190</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">24839611</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.reutlinger.2010.1870">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reutlinger</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helbig</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gawelczyk</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Subero</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonnies</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muhle</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finsterwalder</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfundt</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanova</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gillessen-Kaesbach</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Spiczak</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Baalen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boor</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siebert</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephani</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caliebe</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Deletions in 16p13 including GRIN2A in patients with intellectual disability, various dysmorphic features, and seizure disorders of the rolandic region.</article-title>
                <source>Epilepsia.</source>
                <year>2010</year>
                <volume>51</volume>
                <fpage>1870</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">20384727</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.scheffer.2000.s19">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant rolandic epilepsy with speech dyspraxia.</article-title>
                <source>Epileptic Disord.</source>
                <year>2000</year>
                <volume>2</volume>
                <supplement>Suppl 1</supplement>
                <fpage>S19</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">11231219</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.staden.1998.242">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Staden</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isaacs</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyd</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brandl</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neville</surname>
                    <given-names>BG</given-names>
                  </name>
                </person-group>
                <article-title>Language dysfunction in children with Rolandic epilepsy.</article-title>
                <source>Neuropediatrics.</source>
                <year>1998</year>
                <volume>29</volume>
                <fpage>242</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9810559</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.striano.2013.360">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Striano</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capovilla</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Epileptic encephalopathy with continuous spikes and waves during sleep.</article-title>
                <source>Curr Neurol Neurosci Rep.</source>
                <year>2013</year>
                <volume>13</volume>
                <fpage>360</fpage>
                <pub-id pub-id-type="pmid">23666433</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.tsai.2013.280">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tsai</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vears</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadleir</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                </person-group>
                <article-title>Clinical genetic study of the epilepsy-aphasia spectrum.</article-title>
                <source>Epilepsia.</source>
                <year>2013</year>
                <volume>54</volume>
                <fpage>280</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23294109</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.turner.2015a.586">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayes</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verhoeven</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandelstam</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                </person-group>
                <article-title>GRIN2A: an aptly named gene for speech dysfunction.</article-title>
                <source>Neurology.</source>
                <year>2015a</year>
                <volume>84</volume>
                <fpage>586</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">25596506</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.turner.2015b.35">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                </person-group>
                <article-title>New genes for focal epilepsies with speech and language disorders.</article-title>
                <source>Curr Neurol Neurosci Rep.</source>
                <year>2015b</year>
                <volume>15</volume>
                <fpage>35</fpage>
                <pub-id pub-id-type="pmid">25921602</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.van_bogaert.2013.635">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Bogaert</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>Epileptic encephalopathy with continuous spike-waves during slow-wave sleep including Landau-Kleffner syndrome.</article-title>
                <source>Handb Clin Neurol.</source>
                <year>2013</year>
                <volume>111</volume>
                <fpage>635</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">23622211</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.venkateswaran.2014.e75">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Venkateswaran</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myers</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beaulieu</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartzentruber</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majewski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bulman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boycott</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dyment</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <article-title>Whole-exome sequencing in an individual with severe global developmental delay and intractable epilepsy identifies a novel, de novo GRIN2A mutation.</article-title>
                <source>Epilepsia.</source>
                <year>2014</year>
                <volume>55</volume>
                <fpage>e75</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24903190</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.wang.2006.105">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bao</surname>
                    <given-names>XH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>YW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>XY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qin</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <comment>[Clinical characteristics and long-term prognosis of Landau-Kleffner syndrome]</comment>
                <source>Zhonghua Er Ke Za Zhi.</source>
                <year>2006</year>
                <volume>44</volume>
                <fpage>105</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16624025</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.worthey.2013.29">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Worthey</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raca</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laffin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilk</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakielski</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dimmock</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strand</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shriberg</surname>
                    <given-names>LD</given-names>
                  </name>
                </person-group>
                <article-title>Whole-exome sequencing supports genetic heterogeneity in childhood apraxia of speech.</article-title>
                <source>J Neurodev Disord.</source>
                <year>2013</year>
                <volume>5</volume>
                <fpage>29</fpage>
                <pub-id pub-id-type="pmid">24083349</pub-id>
              </element-citation>
            </ref>
            <ref id="grin2a-dis.REF.yuan.2014.3251">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierson</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markello</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fajardo</surname>
                    <given-names>KV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holloman</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Golas</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adams</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boerkoel</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traynelis</surname>
                    <given-names>SF</given-names>
                  </name>
                </person-group>
                <article-title>Functional analysis of a de novo GRIN2A missense mutation associated with early-onset epileptic encephalopathy.</article-title>
                <source>Nat Commun.</source>
                <year>2014</year>
                <volume>5</volume>
                <fpage>3251</fpage>
                <pub-id pub-id-type="pmid">24504326</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="grin2a-dis.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="grin2a-dis.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>29 September 2016 (bp) Review posted live</p>
            </list-item>
            <list-item>
              <p>12 October 2015 (kam) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
